We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Wellcome Trust Sanger Institute

The Wellcome Trust Sanger Institute is one of the world's leading centres of genome sequencing and analysis.

Under founder director John (now Sir John) Sulston, the Sanger Institute spearheaded the UK contribution to the Human Genome Project. It sequenced almost one-third of the human genome (the largest single contribution) and was instrumental in ensuring that sequence data were made freely available for the benefit of all.

As well as the human genome, the Sanger Institute has sequenced the genomes of numerous disease-causing microbes, including those that cause tuberculosis, malaria, leprosy and diphtheria.

Under the current director Allan Bradley, focus has shifted to the use of genome sequence data and the development of high-throughput methods to answer important biological questions and the role of genes in health and disease. The breadth of the Institute's work has expanded, and in the past two years nearly 20 new senior project leaders have been recruited. New laboratories are being built to house these new studies.

The Wellcome Trust Sanger Institute is named in honour of Fred Sanger, a double Nobel Laureate who devised the method for DNA sequencing used in the Human Genome Project.

Share |
Home  >  Funding  >  Biomedical science  >  Funded projects  >  Major initiatives  >  Wellcome Trust Sanger Institute  > Sanger Institute
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888